Alexander pointed out that the study did not aim to assess the effectiveness of buprenorphine but rather “raises (the) question about how we can improve the quality and continuity of this treatment.” The study looked at 38,096 buprenorphine users between January 2010 and July 2012, with an average treatment length of 55 days.